These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15258110)

  • 21. Repurposing Resveratrol and Fluconazole To Modulate Human Cytochrome P450-Mediated Arachidonic Acid Metabolism.
    El-Sherbeni AA; El-Kadi AO
    Mol Pharm; 2016 Apr; 13(4):1278-88. PubMed ID: 26918316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse endometrium stromal cells express a polycyclic aromatic hydrocarbon-inducible cytochrome P450 that closely resembles the novel P450 in mouse embryo fibroblasts (P450EF).
    Savas U; Christou M; Jefcoate CR
    Carcinogenesis; 1993 Oct; 14(10):2013-8. PubMed ID: 8222047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.
    Chang TK; Chen J; Benetton SA
    Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes: evidence for species-specific differences in responses.
    Lee CA; Lawrence BP; Kerkvliet NI; Rifkind AB
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):1-11. PubMed ID: 9875294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate.
    Uno S; Dalton TP; Dragin N; Curran CP; Derkenne S; Miller ML; Shertzer HG; Gonzalez FJ; Nebert DW
    Mol Pharmacol; 2006 Apr; 69(4):1103-14. PubMed ID: 16377763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
    Angus WG; Larsen MC; Jefcoate CR
    Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas.
    Buters JT; Sakai S; Richter T; Pineau T; Alexander DL; Savas U; Doehmer J; Ward JM; Jefcoate CR; Gonzalez FJ
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1977-82. PubMed ID: 10051580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow stromal cells constitutively express high levels of cytochrome P4501B1 that metabolize 7,12-dimethylbenz[a]anthracene.
    Heidel SM; Czuprynski CJ; Jefcoate CR
    Mol Pharmacol; 1998 Dec; 54(6):1000-6. PubMed ID: 9855628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1.
    Crofts FG; Sutter TR; Strickland PT
    Carcinogenesis; 1998 Nov; 19(11):1969-73. PubMed ID: 9855011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial targeting of mouse NQO1 and CYP1B1 proteins.
    Dong H; Shertzer HG; Genter MB; Gonzalez FJ; Vasiliou V; Jefcoate C; Nebert DW
    Biochem Biophys Res Commun; 2013 Jun; 435(4):727-32. PubMed ID: 23692925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 7H-dibenzo[c,g]carbazole metabolism by the mouse and human CYP1 family of enzymes.
    Shertzer HG; Genter MB; Talaska G; Curran CP; Nebert DW; Dalton TP
    Carcinogenesis; 2007 Jun; 28(6):1371-8. PubMed ID: 17166882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1.
    Kim JH; Stansbury KH; Walker NJ; Trush MA; Strickland PT; Sutter TR
    Carcinogenesis; 1998 Oct; 19(10):1847-53. PubMed ID: 9806168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha.
    Sparfel L; Van Grevenynghe J; Le Vee M; Aninat C; Fardel O
    Carcinogenesis; 2006 Mar; 27(3):656-63. PubMed ID: 16258175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition.
    Lo SN; Shen CC; Chang CY; Tsai KC; Huang CC; Wu TS; Ueng YF
    Drug Metab Dispos; 2015 Jul; 43(7):1100-7. PubMed ID: 25953522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 7,12-Dimethylbenzanthracene induces apoptosis in RL95-2 human endometrial cancer cells: ligand-selective activation of cytochrome P450 1B1.
    Kim JY; Lee SG; Chung JY; Kim YJ; Park JE; Oh S; Lee SY; Choi HJ; Yoo YH; Kim JM
    Toxicol Appl Pharmacol; 2012 Apr; 260(2):124-34. PubMed ID: 22570863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues.
    Muskhelishvili L; Thompson PA; Kusewitt DF; Wang C; Kadlubar FF
    J Histochem Cytochem; 2001 Feb; 49(2):229-36. PubMed ID: 11156691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
    Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
    Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of melatonin by human cytochromes p450.
    Ma X; Idle JR; Krausz KW; Gonzalez FJ
    Drug Metab Dispos; 2005 Apr; 33(4):489-94. PubMed ID: 15616152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
    Rochat B; Morsman JM; Murray GI; Figg WD; McLeod HL
    J Pharmacol Exp Ther; 2001 Feb; 296(2):537-41. PubMed ID: 11160641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.